The Valley Desk

NCT01789242 · Interventional trial

A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis

Overall registry status Completed

Phase 1

Conditions Amyloidosis, Systemic Light Chain Amyloidosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov